 | ARNA Panacea (ARNA)ICO ARNA Panacea is a blockchain technology based biotech ecosystem. IMPORTANT: By investing in this business you agree to ourDisclaimer. All information including our rating, is provided merely for informational purposes. CryptoTotem does not provide investment advice. |
Overview
|
OpenWhat is ARNA Panacea
ARNA Panacea is platform which allows not processing of clinical trials data and also support for researchers during R&D phase and marketplace for all types of market participants involved in clinical trials as well as direct sales of final biotech products to customers (patients). The platforms initial purpose is to gain, store and analyze information on all the methods of cancer detection and treatment from all over the world. This would allow researchers getting more accurate and precise knowledge on the subject on one hand, and on the other will provide trustable and accessible proof to all market participants on research results conducted throughout their lifecycle.
DetailsPre-sales: Oct 09, 2017 - Nov 11, 2017Public sales: Dec 14, 2017 - Feb 09, 2018 Soft cap: 1,000,000 USD Hard cap: 40,000,000 USD Raised: 329,227 USD LegalRegistration country: Russian FederationRegistration year: 2013 Office address: Moscow BountyBounty: 1%Translation: 15% Social media: 45% Bitcoin talk signature campaign: 30 % | Token infoTicker: ARNAType: Utility-token Token standard: ERC-20 Token price in USD: 1 Token = 1.000000 USD Accepted currencies: ETH Token distribution: The total amount of ARNA tokens is 1 billion. 500 million tokens ARNA will be sold at a fix price 0.08$ for one token during token sale. 30% for development of the ARNA Panacea platform 10% for the founding team of ARNA Genomics 10% for the participants of the project team |
ARNA Panacea Roadmap
ARNA Genomics was established
Seed round; Development of ARNA-Thermometr, a test for the presence of oncological diseases; Know-how objects formalization
Development of ARNA Breast Cancer - a high-precision test for early detection of breast cancer
Development of ARNA Colon Cancer; ARNA BC development is completed; Beginning of laboratory tests of ARNA BC; Submission of patent application No 1
End of laboratory tests of ARNA BC; Start of ARNA BC clinical research jointly with Sechenov University; Submission of application of Patent Cooperation Treaty No 1; Token Distribution Event
- Opening of the office and the 1st laboratory unit in the USA.
- Submission of application of Patent Cooperation Treaty No 2 and 3.
- Agreement of the regulatory strategy for ARNA BC. Launch of clinical research No 1 in the USA with FDA.
- ARNA CC development is completed, starting laboratory research.
- ARNA Panacea launch of the beta version of blockchain-ecosystem, basic documentation for develop
- Using of ARNA Panaceas blockchain ecosystem by interested market players (regulators, investors, users, etc.)
- Start of development: ARNA Lung, ARNA Liver, ARNA Pancreas;
- ARNA BCs entry into the US market;
- Clinical trials in China;
- National phases: USA, China, India, EU, UK, Israel, Brazil;
- Seed round B;
- Receiving the first revenue.
Project team
Advisors
Social media
